New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides
Authorized Users Only
2011
Authors
Pešić, Milica
Bankovic, Jasna
Aljančić, Ivana
Todorović, Nina

Jadranin, Milka

Vajs, Vlatka
Tešević, Vele

Vučković, Ivan

Momcilovic, Miljana

Markovic, Ivanka D.

Tanic, Nikola
Ruzdijic, Sabera
Article (Published version)

Metadata
Show full item recordAbstract
Jatrophane diterpenes were shown to be inhibitors of P-glycoprotein (P-gp). There are also evidences on their microtubule-interacting activity in cancer cells. We evaluated new anti-cancer characteristics of two jatrophane type compounds from Euphorbia dendroides. For that purpose, the model system of sensitive non-small cell lung cancer cell line (NCI-H460) and its resistant counterpart (NCI-H460/R) was used. Although both jatrophanes showed inhibitory effect on cancer cell growth, they were non-toxic for peripheral blood mononuclear cells (PBMC). We examined their effects in combination with paclitaxel (PTX), a well-known mitotic spindle interacting chemotherapeutic. Jatrophanes overcome PTX resistance in concentration-dependent manner in MDR cancer cell line (NCI-H460/R). We observed that this synergistic effect is not caused merely by P-gp inhibition. In combination with PTX, jatrophanes induce cell killing and change cell cycle distribution leading to G2/M arrest. Furthermore, the...y exert an anti-angiogenic effect by decreasing the vascular endothelial growth factor (VEGF) secretion. The reduction of the level of mdr1 mRNA expression in sensitive cells, suggests that these compounds could not contribute to the development of resistance. In conclusion, present study provides a rational basis for the new cancer treatment approach with jatrophanes that are non-toxic to normal cells and have new favorable anti-cancer characteristics.
Keywords:
Jatrophane / Spurge / Multi-drug resistance (MDR) / Paclitaxel / Apoptosis / Vascular endothelial growth factor (VEGF)Source:
Food and Chemical Toxicology, 2011, 49, 12, 3165-3173Publisher:
- Oxford : Pergamon-Elsevier Science Ltd
Funding / projects:
- Identification of predictive molecular markers for cancer progression, response to therapy and disease outcome (RS-41031)
- Natural products of wild, cultivated and edible plants: structure and bioactivity determination (RS-172053)
DOI: 10.1016/j.fct.2011.09.035
ISSN: 0278-6915
PubMed: 21996302
WoS: 000298202400023
Scopus: 2-s2.0-80054874373
Collections
Institution/Community
IHTMTY - JOUR AU - Pešić, Milica AU - Bankovic, Jasna AU - Aljančić, Ivana AU - Todorović, Nina AU - Jadranin, Milka AU - Vajs, Vlatka AU - Tešević, Vele AU - Vučković, Ivan AU - Momcilovic, Miljana AU - Markovic, Ivanka D. AU - Tanic, Nikola AU - Ruzdijic, Sabera PY - 2011 UR - https://cer.ihtm.bg.ac.rs/handle/123456789/830 AB - Jatrophane diterpenes were shown to be inhibitors of P-glycoprotein (P-gp). There are also evidences on their microtubule-interacting activity in cancer cells. We evaluated new anti-cancer characteristics of two jatrophane type compounds from Euphorbia dendroides. For that purpose, the model system of sensitive non-small cell lung cancer cell line (NCI-H460) and its resistant counterpart (NCI-H460/R) was used. Although both jatrophanes showed inhibitory effect on cancer cell growth, they were non-toxic for peripheral blood mononuclear cells (PBMC). We examined their effects in combination with paclitaxel (PTX), a well-known mitotic spindle interacting chemotherapeutic. Jatrophanes overcome PTX resistance in concentration-dependent manner in MDR cancer cell line (NCI-H460/R). We observed that this synergistic effect is not caused merely by P-gp inhibition. In combination with PTX, jatrophanes induce cell killing and change cell cycle distribution leading to G2/M arrest. Furthermore, they exert an anti-angiogenic effect by decreasing the vascular endothelial growth factor (VEGF) secretion. The reduction of the level of mdr1 mRNA expression in sensitive cells, suggests that these compounds could not contribute to the development of resistance. In conclusion, present study provides a rational basis for the new cancer treatment approach with jatrophanes that are non-toxic to normal cells and have new favorable anti-cancer characteristics. PB - Oxford : Pergamon-Elsevier Science Ltd T2 - Food and Chemical Toxicology T1 - New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides VL - 49 IS - 12 SP - 3165 EP - 3173 DO - 10.1016/j.fct.2011.09.035 ER -
@article{ author = "Pešić, Milica and Bankovic, Jasna and Aljančić, Ivana and Todorović, Nina and Jadranin, Milka and Vajs, Vlatka and Tešević, Vele and Vučković, Ivan and Momcilovic, Miljana and Markovic, Ivanka D. and Tanic, Nikola and Ruzdijic, Sabera", year = "2011", abstract = "Jatrophane diterpenes were shown to be inhibitors of P-glycoprotein (P-gp). There are also evidences on their microtubule-interacting activity in cancer cells. We evaluated new anti-cancer characteristics of two jatrophane type compounds from Euphorbia dendroides. For that purpose, the model system of sensitive non-small cell lung cancer cell line (NCI-H460) and its resistant counterpart (NCI-H460/R) was used. Although both jatrophanes showed inhibitory effect on cancer cell growth, they were non-toxic for peripheral blood mononuclear cells (PBMC). We examined their effects in combination with paclitaxel (PTX), a well-known mitotic spindle interacting chemotherapeutic. Jatrophanes overcome PTX resistance in concentration-dependent manner in MDR cancer cell line (NCI-H460/R). We observed that this synergistic effect is not caused merely by P-gp inhibition. In combination with PTX, jatrophanes induce cell killing and change cell cycle distribution leading to G2/M arrest. Furthermore, they exert an anti-angiogenic effect by decreasing the vascular endothelial growth factor (VEGF) secretion. The reduction of the level of mdr1 mRNA expression in sensitive cells, suggests that these compounds could not contribute to the development of resistance. In conclusion, present study provides a rational basis for the new cancer treatment approach with jatrophanes that are non-toxic to normal cells and have new favorable anti-cancer characteristics.", publisher = "Oxford : Pergamon-Elsevier Science Ltd", journal = "Food and Chemical Toxicology", title = "New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides", volume = "49", number = "12", pages = "3165-3173", doi = "10.1016/j.fct.2011.09.035" }
Pešić, M., Bankovic, J., Aljančić, I., Todorović, N., Jadranin, M., Vajs, V., Tešević, V., Vučković, I., Momcilovic, M., Markovic, I. D., Tanic, N.,& Ruzdijic, S.. (2011). New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides. in Food and Chemical Toxicology Oxford : Pergamon-Elsevier Science Ltd., 49(12), 3165-3173. https://doi.org/10.1016/j.fct.2011.09.035
Pešić M, Bankovic J, Aljančić I, Todorović N, Jadranin M, Vajs V, Tešević V, Vučković I, Momcilovic M, Markovic ID, Tanic N, Ruzdijic S. New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides. in Food and Chemical Toxicology. 2011;49(12):3165-3173. doi:10.1016/j.fct.2011.09.035 .
Pešić, Milica, Bankovic, Jasna, Aljančić, Ivana, Todorović, Nina, Jadranin, Milka, Vajs, Vlatka, Tešević, Vele, Vučković, Ivan, Momcilovic, Miljana, Markovic, Ivanka D., Tanic, Nikola, Ruzdijic, Sabera, "New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides" in Food and Chemical Toxicology, 49, no. 12 (2011):3165-3173, https://doi.org/10.1016/j.fct.2011.09.035 . .